DDrare: Database of Drug Development for Rare Diseases

Ta-650 (infliximab) (DrugBank: Infliximab)

3 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
97	Ulcerative colitis	1
271	Ankylosing spondylitis	1

46. Malignant rheumatoid arthritis [ 4,183 clinical trials, 2,538 drugs, (DrugBank: 401 drugs), 183 drug target genes, 219 drug target pathways]

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 4,183 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-050146		12/10/2005	Clinical Study to assess the efficacy and safety of increased dose of TA-650 in patients with Rheumatoid Arthritis	Clinical Study to assess the efficacy and safety of increased dose of TA-650 in patients with Rheumatoid Arthritis	Rheumatoid Arthritis	Intervention name : TA-650 (Infliximab) Dosage And administration of the intervention : Intravenous drip infusion	Mitsubishi Tanabe Pharma Corporation	NULL		20	75	BOTH		Phase 3	NULL

97. Ulcerative colitis [ 2,269 clinical trials, 1,331 drugs, (DrugBank: 241 drugs), 114 drug target genes, 181 drug target pathways]

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,269 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-060298		24/08/2006	Clinical study to assess the efficacy and safety of TA-650 in patients with active ulcerative colitis	Clinical study to assess the efficacy and safety of TA-650 in patients with active ulcerative colitis	Ulcerative colitis	Intervention name : TA-650 (Infliximab) Dosage And administration of the intervention : Intravenous drip infusion	Mitsubishi Tanabe Pharma Corporation	NULL		16		BOTH		Phase 3	NULL

271. Ankylosing spondylitis [ 531 clinical trials, 343 drugs, (DrugBank: 66 drugs), 41 drug target genes, 141 drug target pathways]

Searched query = "Ankylosing spondylitis", "Spondylarthritis ankylopoietica"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 531 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-070346		22/01/2007	Clinical study of TA-650 in patients with ankylosing spondylitis	Clinical study of TA-650 in patients with ankylosing spondylitis	Ankylosing spondylitis	Intervention name : TA-650 (Infliximab) Dosage And administration of the intervention : Intravenous drip infusion	Mitsubishi Tanabe Pharma Corporation	NULL		16		BOTH		Phase 3	NULL